Cyanotech

Cyanotech Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Cyanotech (CYAN) as of Nov 21, 2026 is -18.25 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 37.25 % — a change of -149.01% (lower).

Cash Conversion

-18.25 %

YoY

-149.01%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Cyanotech is 2026 -18.25 % . Cash Conversion Rate (OCF/Net Income) of Cyanotech was 2025 37.25 % . It decreases by -149.01% lower compared to the previous year.

The Cyanotech Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2019
23.55 USD
Jan 1, 2020
321.19 USD
Jan 1, 2021
260.87 USD
Jan 1, 2022
110.45 USD
Jan 1, 2023
61.05 USD
Jan 1, 2024
8.64 USD
Jan 1, 2025
37.25 USD
Jan 1, 2026
-18.25 USD
The Cyanotech Cash Conversion history
YEARCash ConversionYoY
-18.25 %-149.01%
37.25 %+331.16%
8.64 %-85.85%
61.05 %-44.73%
110.45 %-57.66%
260.87 %-18.78%
321.19 %+1,263.63%
23.55 %-83.80%
145.37 %-244.77%
-100.41 %+492.36%
-16.95 %-99.67%
-5,162.50 %+368.44%
-1,102.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyanotech Stock analysis

What does Cyanotech do? Cyanotech Corp develops and commercializes natural products from microalgae, focusing on Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement providing energy, immune support, cardiovascular benefits, and antioxidant carotenoids. Hawaiian BioAstin supports inflammatory response, skin health, eye health, and joint health as a dietary antioxidant. The company cultivates two microalgal species in Hawaii, producing natural astaxanthin and spirulina products. Finished products are manufactured in Hawaii and California, with the firm targeting health-conscious consumers seeking natural supplements. The company's revenue streams come from direct sales of Hawaiian Spirulina Pacifica and Hawaiian BioAstin to consumers through retail channels and online platforms. These products are sold under their respective brand names, with no additional brands or product lines mentioned. The firm's primary market segment consists of individuals interested in dietary supplements for wellness, immune support, and natural health solutions, emphasizing the Hawaiian origin and natural sourcing of their products. Cyanotech Corp's business model relies on the cultivation of microalgae in Hawaii, where it produces raw materials for its product lines. The manufacturing of finished products occurs in Hawaii and California, ensuring quality control and adherence to natural product standards. The company's focus on natural, health-oriented products appeals to a specific demographic of health enthusiasts and consumers prioritizing natural ingredients in their wellness routines. Cyanotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyanotech stock

Cash Conversion Rate (OCF/Net Income) of Cyanotech is -18.25 % in 2026.

Cash Conversion Rate (OCF/Net Income) of Cyanotech changed from 37.25 % to -18.25 %, representing a -149.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Cyanotech since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Cyanotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cyanotech

All Key Metrics — Cyanotech